Vanderbilt-Ingram Cancer Center ( Site 0038) — Nashville, Tennessee

Vanderbilt-Ingram Cancer Center ( Site 0038) is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingram Cancer Center ( Site 0038) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingram Cancer Center ( Site 0038)?

Vanderbilt-Ingram Cancer Center ( Site 0038) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingram Cancer Center ( Site 0038) conducted?

Vanderbilt-Ingram Cancer Center ( Site 0038) has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms.

Is Vanderbilt-Ingram Cancer Center ( Site 0038) accredited by Crixeo Health?

Vanderbilt-Ingram Cancer Center ( Site 0038) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingram Cancer Center ( Site 0038)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.